S&P 500   4,240.81 (-0.77%)
DOW   33,319.09 (-0.89%)
QQQ   352.19 (-0.57%)
AAPL   169.50 (-1.43%)
MSFT   310.45 (-0.54%)
META   297.26 (-0.57%)
GOOGL   129.39 (+0.64%)
AMZN   125.17 (-0.64%)
TSLA   235.65 (-3.47%)
NVDA   418.16 (-0.23%)
NIO   8.31 (-1.19%)
BABA   85.54 (-0.43%)
AMD   96.96 (+1.04%)
T   14.81 (-1.40%)
F   12.26 (-1.37%)
MU   67.05 (-1.31%)
CGC   0.87 (-5.88%)
GE   110.50 (+0.52%)
DIS   79.32 (-0.91%)
AMC   7.70 (-2.65%)
PFE   31.91 (-1.51%)
PYPL   56.78 (-3.65%)
NFLX   377.40 (-0.49%)
S&P 500   4,240.81 (-0.77%)
DOW   33,319.09 (-0.89%)
QQQ   352.19 (-0.57%)
AAPL   169.50 (-1.43%)
MSFT   310.45 (-0.54%)
META   297.26 (-0.57%)
GOOGL   129.39 (+0.64%)
AMZN   125.17 (-0.64%)
TSLA   235.65 (-3.47%)
NVDA   418.16 (-0.23%)
NIO   8.31 (-1.19%)
BABA   85.54 (-0.43%)
AMD   96.96 (+1.04%)
T   14.81 (-1.40%)
F   12.26 (-1.37%)
MU   67.05 (-1.31%)
CGC   0.87 (-5.88%)
GE   110.50 (+0.52%)
DIS   79.32 (-0.91%)
AMC   7.70 (-2.65%)
PFE   31.91 (-1.51%)
PYPL   56.78 (-3.65%)
NFLX   377.40 (-0.49%)
S&P 500   4,240.81 (-0.77%)
DOW   33,319.09 (-0.89%)
QQQ   352.19 (-0.57%)
AAPL   169.50 (-1.43%)
MSFT   310.45 (-0.54%)
META   297.26 (-0.57%)
GOOGL   129.39 (+0.64%)
AMZN   125.17 (-0.64%)
TSLA   235.65 (-3.47%)
NVDA   418.16 (-0.23%)
NIO   8.31 (-1.19%)
BABA   85.54 (-0.43%)
AMD   96.96 (+1.04%)
T   14.81 (-1.40%)
F   12.26 (-1.37%)
MU   67.05 (-1.31%)
CGC   0.87 (-5.88%)
GE   110.50 (+0.52%)
DIS   79.32 (-0.91%)
AMC   7.70 (-2.65%)
PFE   31.91 (-1.51%)
PYPL   56.78 (-3.65%)
NFLX   377.40 (-0.49%)
S&P 500   4,240.81 (-0.77%)
DOW   33,319.09 (-0.89%)
QQQ   352.19 (-0.57%)
AAPL   169.50 (-1.43%)
MSFT   310.45 (-0.54%)
META   297.26 (-0.57%)
GOOGL   129.39 (+0.64%)
AMZN   125.17 (-0.64%)
TSLA   235.65 (-3.47%)
NVDA   418.16 (-0.23%)
NIO   8.31 (-1.19%)
BABA   85.54 (-0.43%)
AMD   96.96 (+1.04%)
T   14.81 (-1.40%)
F   12.26 (-1.37%)
MU   67.05 (-1.31%)
CGC   0.87 (-5.88%)
GE   110.50 (+0.52%)
DIS   79.32 (-0.91%)
AMC   7.70 (-2.65%)
PFE   31.91 (-1.51%)
PYPL   56.78 (-3.65%)
NFLX   377.40 (-0.49%)
NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Forecast, Price & News

$1.18
0.00 (0.00%)
(As of 01:07 PM ET)
Compare
Today's Range
$1.16
$1.21
50-Day Range
$1.18
$1.84
52-Week Range
$0.67
$2.05
Volume
14,984 shs
Average Volume
294,960 shs
Market Capitalization
$224.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.98

Aveanna Healthcare MarketRank™ Forecast

Analyst Rating
Reduce
1.80 Rating Score
Upside/​Downside
65.3% Upside
$1.98 Price Target
Short Interest
Bearish
3.20% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Aveanna Healthcare in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.17) to ($0.12) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

901st out of 963 stocks

Home Health Care Services Industry

6th out of 7 stocks


AVAH stock logo

About Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

AVAH Price History

AVAH Stock News Headlines

Aveanna Healthcare (NASDAQ:AVAH) Stock Price Down 4.8%
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Q2 2023 Aveanna Healthcare Holdings Inc Earnings Call
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Short Volatility Alert: Aveanna Healthcare
Aveanna Healthcare Holdings (AVAH) Gets a Sell from Credit Suisse
See More Headlines
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

AVAH Company Calendar

Last Earnings
8/10/2023
Today
9/27/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVAH
Fax
N/A
Employees
3,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$1.98
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+68.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.80
Research Coverage
5 Analysts

Profitability

Net Income
$-662,030,000.00
Pretax Margin
-12.18%

Debt

Sales & Book Value

Annual Sales
$1.79 billion
Cash Flow
$3.58 per share
Book Value
($0.03) per share

Miscellaneous

Free Float
177,286,000
Market Cap
$224.71 million
Optionable
Not Optionable
Beta
1.21
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Rodney D. Windley (Age 75)
    Exec. Chairman
    Comp: $2.28M
  • Mr. Jeffrey S. Shaner (Age 50)
    CEO & Director
    Comp: $551.42k
  • Mr. Shannon L. Drake (Age 48)
    Chief Legal Officer & Sec.
    Comp: $401.32k
  • Mr. Matt Buckhalter
    Interim CFO & Principal Financial Officer
  • Ms. Debbie Stewart
    Sr. VP & Principal Accounting Officer
  • Mr. Ed Reisz (Age 64)
    Chief Admin. Officer
  • Mr. Patrick A. Cunningham (Age 67)
    Chief Compliance Officer
  • Ms. Beth Rubio (Age 66)
    Chief Clinical Officer
  • Ms. Korey Hinz
    Pres of Medical Solutions
  • Ms. Kristy Rohwedder
    Pres of Private Duty Nursing













AVAH Stock - Frequently Asked Questions

Should I buy or sell Aveanna Healthcare stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last year. There are currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" AVAH shares.
View AVAH analyst ratings
or view top-rated stocks.

What is Aveanna Healthcare's stock price forecast for 2023?

5 Wall Street research analysts have issued twelve-month target prices for Aveanna Healthcare's shares. Their AVAH share price forecasts range from $1.00 to $3.00. On average, they expect the company's share price to reach $1.98 in the next twelve months. This suggests a possible upside of 68.1% from the stock's current price.
View analysts price targets for AVAH
or view top-rated stocks among Wall Street analysts.

How have AVAH shares performed in 2023?

Aveanna Healthcare's stock was trading at $0.78 at the beginning of 2023. Since then, AVAH stock has increased by 51.3% and is now trading at $1.18.
View the best growth stocks for 2023 here
.

When is Aveanna Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our AVAH earnings forecast
.

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) issued its earnings results on Thursday, August, 10th. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.04) by $0.02. The firm had revenue of $471.95 million for the quarter, compared to the consensus estimate of $453.19 million. Aveanna Healthcare had a negative net margin of 12.00% and a negative trailing twelve-month return on equity of 70.08%. During the same period in the previous year, the firm earned $0.03 earnings per share.

What guidance has Aveanna Healthcare issued on next quarter's earnings?

Aveanna Healthcare updated its FY 2023 earnings guidance on Sunday, August, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.85 billion-$1.86 billion, compared to the consensus revenue estimate of $1.87 billion.

When did Aveanna Healthcare IPO?

(AVAH) raised $478 million in an initial public offering on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

What is Aveanna Healthcare's stock symbol?

Aveanna Healthcare trades on the NASDAQ under the ticker symbol "AVAH."

Who are Aveanna Healthcare's major shareholders?

Aveanna Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include Nut Tree Capital Management LP (5.82%), Littlejohn & Co. LLC (3.42%), King Street Capital Management L.P. (2.00%), BlackRock Inc. (1.88%), Principal Financial Group Inc. (1.71%) and Geode Capital Management LLC (0.57%). Insiders that own company stock include David Afshar, Jeff Shaner, Patrick A Cunningham, Steven E Rodgers, Tony Strange and Victor F Ganzi.
View institutional ownership trends
.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aveanna Healthcare's stock price today?

One share of AVAH stock can currently be purchased for approximately $1.18.

How much money does Aveanna Healthcare make?

Aveanna Healthcare (NASDAQ:AVAH) has a market capitalization of $224.71 million and generates $1.79 billion in revenue each year. The company earns $-662,030,000.00 in net income (profit) each year or ($1.19) on an earnings per share basis.

How many employees does Aveanna Healthcare have?

The company employs 3,700 workers across the globe.

How can I contact Aveanna Healthcare?

Aveanna Healthcare's mailing address is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. The official website for the company is www.aveanna.com. The company can be reached via phone at 770-441-1580 or via email at ir@aveanna.com.

This page (NASDAQ:AVAH) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -